Drugstore chain CVS Health Corp. in recent weeks has been reviewing its options as a company — among them a potential breakup — the Wall Street Journal reported on Monday.
CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes amid pressure from investors, people familiar with the matter told Reuters.
CVS has faced consecutive guidance downgrades and a significant share price drop due to underperformance in its Medicare Advantage segment and rising costs. CEO Lynch's leadership is under scrutiny, with hedge fund Glenview Capital pushing for strategic changes, potentially including management overhaul, and requesting meetings with senior management. Despite current struggles, CVS's long-term potential remains, hinging on improving Medicare Advantage margins and avoiding further downgrades.
“Sell at former peaks” is an old Wall Street expression. People say this because stocks tend to run into resistance when they rally to a price level that has been a peak.
CVS Health is reportedly meeting with a top investor on ways to enhance its business. The pharmacy/healthcare chain was set to meet Monday (Sept.
CVS Health (CVS) shares rose Monday on a report that major investor hedge fund Glenview Capital Management was planning to hold a meeting today with executives of the pharmacy and health care firm about making changes to its operations.
Hedge fund mogul Larry Robbins will meet with executives at struggling drugstore chain CVS on Monday to present a turnaround plan that the Glenview Capital founder hopes will improve the firm's operations, according to a report.
Gathering signals potential changes to improve shareholder value after the company's weak stock performance.
Glenview Capital Management will meet with top CVS executives to exchange ideas on how to make improvements at the healthcare company, according to a report from The Wall Street Journal.
Glenview Capital has amassed a sizable stake in CVS Health and plans to meet with the company's top executives to lay out its plan for value creation, according to people familiar with the matter. The proposal is seen as a precursor to an activist push at the company, the people said.
The hedge fund has taken a large position in the healthcare company, which has seen its shares fall 24% this year to date
Healthcare-focused Glenview Capital Management has established a large position in CVS Health and will meet top executives at the struggling healthcare company on Monday to propose ways it can improve its operations, The Wall Street Journal reported on Sunday.